Trial Profile
A study of the pharmacokinetics of new formulation lopinavir/ritonavir in the genital tract and plasma of HIV infected women in pregnancy
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 28 Nov 2018
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics; Therapeutic Use
- 28 Nov 2018 New trial record
- 13 Oct 2018 Results published in the European Clinical Trials Database record.